Summer Bud Guide
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. IndustryTHCCBDSafetyDosingResearchPolicy Why This Matters Clinicians should understand that patients increasingly make…
Clinical Trial: High Doses of CBD Superior to Placebo in Treating Neuropathic Pain
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDPainResearchNeurologyDosingSafetyPolicy Why This Matters This trial provides clinicians with evidence-based dosing…
PleoPharma Announces 1st Patient Dosed in Phase 3 Clinical Trial for Cannabis Use Disorder
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyCBDDosingHempIndustry Why This Matters This Phase 3 trial represents progress toward a…
Cannabis Warning Label Regulations and Characteristics in US States with Medical and …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyDosingMental HealthPediatricsTHC Why This Matters Clinicians need standardized, evidence-based…
Alleviates Community Chronic Pain and Inflammation Accelerate
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainCBDResearchSafetyPolicyAnxietyMental Health Why This Matters Clinicians treating rheumatoid arthritis patients…
Guest columnist: Washington should ensure stable hemp market | State-Journal
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempCBDIndustrySafetyResearchDosing Why This Matters Clinicians prescribing or recommending hemp-derived…
Cannabinoid-Based Therapies Linked to Reduced Agitation in Alzheimer’s Patients, Meta …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyCBDAgingMental HealthSafetyTHC Why This Matters Clinicians managing behavioral symptoms in…
Michigan universities can’t study dispensary pot on campus. MSU went mobile
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustryNeurologyMental HealthAnxiety Why This Matters Restrictions on campus-based cannabis research…
DEA Judge Issues Order Laying Out Process For Marijuana Rescheduling Hearing Starting …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyTHCHempIndustryMental Health Why This Matters Clinicians need to understand this regulatory…
PleoPharma Announces 1st Patient Dosed in Phase 3 Clinical Trial for Cannabis Use Disorder
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthCBDSafetyDosingIndustryHemp Why This Matters Clinicians currently lack FDA-approved pharmacotherapy…